Janssen-Cilag Ltd: UK Public Sector Contracts Won & Awards
Large organisation·Companies House: Private Limited Company·High Wycombe·South East England·Main market: Pharmaceutical products
Official UK PPONPTBW-9923-RLZDCompanies House01027904 ↗ · Active
Where they wini
i
87 awards (84 for a named lot, 97%, 3 for a whole procedure with no lot named) · top CPV classes, shares of all 87 awards. An award may cover more than one class.
3360 Pharmaceutical products87 awards · 100% · 84 awards naming a lot + 3 whole-procedure awardsi
Largest published awards i | Authority | Awarded | Term | Published value |
|---|---|---|---|---|
| Biologic and Biosimilar Medicines | eTenderwales | — | — | £555,400 † |
Where their buyers arei
i
ITL1 region of the buyer office · known for 67 of 67 awarded procedures · each procedure counts once
Bidding recordi
i
Procurement Act 2023 award notices name every bidder · 6 notices name this supplier, covering 8 lots since 17 Oct 2025 · observed bids, not an estimate
i
i
i
| Notice | Authority | Outcome | Bidders | Published |
|---|---|---|---|---|
| NHS National Generic Pharmaceuticals - Wave 16a | NHS England | not appointed | 125 | 9 Oct 2026 |
| NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 | NHS England | appointedall 2 lots bid for | 26 | 10 Jul 2026 |
| NHS National Generics Pharmaceuticals - Supply Chain Resilience | NHS England | appointed | 41 | 6 Jul 2026 |
| NHS National Branded Interim - 1 June 2026 | NHS England | appointed | 53 | 22 May 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | NHS England | not appointed | 118 | 26 Feb 2026 |
| NHS National Framework for Golimumab Injection | NHS England | appointed | 3 | 17 Oct 2025 |
Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.
Who they sell toi
i
Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier
i
NHS & health85%(74 awards)
74 of 87 awards are NHS & health (85%).Type not classified15%(13 awards)
13 of 87 awards are Type not classified (15%).
| Authority | Procedures | Share | Award records | Last activity |
|---|---|---|---|---|
| NHS England | 42 | 62.7% | 63 | 6 Jul 2026 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | 14 | 20.9% | 22 | 18 Jul 2026 |
| The NHS Commissioning Board (operating under the name of NHS England) | 5 | 7.5% | 7 | 7 Feb 2022 |
| Business Services Organisation Procurement and Logistics Service | 3 | 4.5% | 9 | 19 Aug 2025 |
| eTenderwales | 1 | 1.5% | 1 | 23 Apr 2025 |
| NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | 1 | 1.5% | 1 | 25 Nov 2025 |
| ATAMIS LTD | 1 | 1.5% | 1 | 7 Jul 2023 |
Share = of the 67 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.
Contracts endingi
i
85 of 104 awards carry an end date, 21 estimated from the duration · not a retender forecast
| Contract | Ends | Published value |
|---|---|---|
| Infliximab IV | 19 Jan 2027 estimated | £44,300,000 ceiling |
| NP49425 Generic and Biosimilar Transition Medicines | 28 Feb 2027 | £64,103,740 ceiling |
| Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept) | 28 Feb 2027 | £26,539,272 ceiling |
| NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1) | 31 May 2027 | Not published |
| Wave 14c - Orals (plus non-parenteral) Products (all regions) | 31 May 2027 | £1 ceiling |
| Medicinal Products - Direct to Trust | 2 Jun 2027 estimated | £210,000,000 ceiling |
| Medicinal Products - with Pharma Funded Homecare Services | 2 Jun 2027 estimated | £174,000,000 ceiling |
| NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | 31 Aug 2027 | £986,282,758 |
| NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National | 31 Aug 2027 | £261,895,933 |
| Lot 2 - CM/PHR/25/5731/02 - Ustekinumab NOFE & MAE | 31 Aug 2027 | £18,903,212 ceiling |
Soonest 10 of 15.
Recent awards
Latest 30 of 87 award records naming this supplier
Other official notice feeds add 17 more procedures won by this supplier. Each is counted once beside any Find a Tender copy; they are in the totals, not in this list.
About this data
- One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
- Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
- Regions in the buyer chart describe the buyer office, not where the work is delivered or the supplier’s registered address.
- Contract end dates. Published on 64 of 104 awards, estimated from the published duration on 21 more (marked “estimated”); those feed “Contracts ending”. Published values in that list come from either source; Contracts Finder figures are shown as published and stay out of this profile’s money totals.
- Source. Official UK public procurement notices (Find a Tender, Contracts Finder and Public Contracts Scotland), reused under the Open Government Licence v3.0, updated through the day and rebuilt nightly. Not every figure uses every feed, and each one shows how many records it rests on: see the methodology. Spotted something wrong? Tell us.